Quality of Life Effects of Continuous Subcutaneous Infusion of Foslevodopa/Foscarbidopa in People with Parkinson’s (P9-3.003)Leonard Verhagen Metman, Jason Aldred, Rajesh Pahwa et al.|Neurology|2024Cited by 0
Efficacy and safety of foslevodopa/foscarbidopa subcutaneous infusion in patients with prior deep brain stimulationTove Henriksen, Victor S.C. Fung, Elizabeth Peckham et al.|Parkinsonism & Related Disorders|2024Cited by 0